tiprankstipranks
Trending News
More News >
Calcimedica, Inc. (CALC)
:CALC
US Market

CalciMedica (CALC) Stock Statistics & Valuation Metrics

Compare
266 Followers

Total Valuation

CalciMedica has a market cap or net worth of $22.91M. The enterprise value is -$8.14M.
Market Cap$22.91M
Enterprise Value-$8.14M

Share Statistics

CalciMedica has 13,971,990 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,971,990
Owned by Insiders56.98%
Owned by Institutions23.05%

Financial Efficiency

CalciMedica’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -150.24%.
Return on Equity (ROE)-0.95
Return on Assets (ROA)-0.69
Return on Invested Capital (ROIC)-150.24%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-978.57K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of CalciMedica is -2.91. CalciMedica’s PEG ratio is 0.13.
PE Ratio-2.91
PS Ratio0.00
PB Ratio0.25
Price to Fair Value2.76
Price to FCF-0.36
Price to Operating Cash Flow-0.39
PEG Ratio0.13

Income Statement

In the last 12 months, CalciMedica had revenue of 0.00 and earned -13.70M in profits. Earnings per share was -12.18.
Revenue0.00
Gross Profit0.00
Operating Income-24.20M
Pretax Income-13.70M
Net Income-13.70M
EBITDA-13.64M
Earnings Per Share (EPS)-12.18

Cash Flow

In the last 12 months, operating cash flow was -32.82M and capital expenditures -17.00K, giving a free cash flow of -32.83M billion.
Operating Cash Flow-32.82M
Free Cash Flow-32.83M
Free Cash Flow per Share-2.35

Dividends & Yields

CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.62
52-Week Price Change-68.76%
50-Day Moving Average1.72
200-Day Moving Average2.81
Relative Strength Index (RSI)40.29
Average Volume (3m)20.26K

Important Dates

CalciMedica upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date

Financial Position

CalciMedica as a current ratio of 5.34, with Debt / Equity ratio of 0.56%
Current Ratio5.34
Quick Ratio5.34
Debt to Market Cap0.00
Net Debt to EBITDA0.58
Interest Coverage Ratio0.00

Taxes

In the past 12 months, CalciMedica has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

CalciMedica EV to EBITDA ratio is -2.34, with an EV/FCF ratio of -1.51.
EV to Sales0.00
EV to EBITDA-2.34
EV to Free Cash Flow-1.51
EV to Operating Cash Flow-1.51

Balance Sheet

CalciMedica has $24.63M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$24.63M billion.
Cash & Marketable Securities$24.63M
Total Debt$0.00
Net Cash-$24.63M
Net Cash Per Share-$1.76
Tangible Book Value Per Share$1.28

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for CalciMedica is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside875.61% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast95.48%

Scores

Smart Score3
AI Score38.5
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis